BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.
The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION ...
IVDR compliance is a critical milestone not only for regulatory readiness, but for the long-term sustainability of ...
IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., an innovator of next generation respiratory technology, announced today that it has received CE (Conformité Européenne) Marking under the European ...
Rockfield Medical Devices Limited Receives CE Mark Approval for the Mobility+® Enteral Feeding System, Marking a Major Milestone in Global Commercial Expansion ...
Add Yahoo as a preferred source to see more of our stories on Google. PCOS affects between 10% and 13% of women worldwide. Image credit: Toey Andante via Shutterstock.com. (Toey Andante via ...
Add Yahoo as a preferred source to see more of our stories on Google. Abbott’s range of paediatric heart treatments also includes the Masters HP 15mm mechanical heart valve. Credit: Michael Vi / ...
The UPC has granted a preliminary injunction effective for Germany, France, Italy, the Netherlands and Ireland against a Chinese medical device manufacturer and its Dutch subsidiary over the ...
New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care Hologic, Inc. (Nasdaq: HOLX) ...
TechLive is a multimodality, vendor-agnostic remote scanning and radiology management solution extending expert oversight across multiple modalities. · GlobeNewswire Inc. SOMERVILLE, Mass., Feb. 26, ...
PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results